Transition Therapeutics, Opko deal

Opko will acquire Transition for $1.55 per share, or about $60 million, in a stock deal. The price is a 121% premium to Transition’s close of $0.70 on June 29, the day before the deal was announced. Opko expects the deal to close in early September, and Transition will become a subsidiary of Opko. Transition did not respond to inquiries. ...